FDA Approves Journavx: A Non-Opioid Painkiller for Acute Pain

casualSTEM delivers brief and informative summaries of the latest science news every Saturday. Full of jokes, silly polls, and a cartoon!

Painkiller 2.0

Non-addictive pain medication has arrived. The FDA approved Journavx, Vertex Pharmaceuticals’ non-opioid painkiller.

• Pronounced: jour-nav-x

• Blocks NaV1.8 sodium channel

• Stops pain signals at the PNS (peripheral nervous system)

By combating pain through the PNS, Journavx avoids reward/pleasure areas of the central nervous system targeted by opioids. Current approval covers short-term moderate-to-severe pain and ongoing trials are testing for expanded applications.

No pain, no problem

Catch-up on science in sweatpants